What are the steps to perform DC (Direct Current) cardioversion for a patient with atrial flutter?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Steps for DC Cardioversion in Atrial Flutter

Direct current (DC) cardioversion is the recommended first-line treatment for restoring sinus rhythm in patients with atrial flutter, especially when a rhythm-control strategy is being pursued or when there is hemodynamic instability.

Pre-Cardioversion Assessment and Preparation

  1. Determine duration of atrial flutter:

    • If ≥48 hours or unknown duration: Anticoagulate with warfarin for at least 3 weeks before cardioversion 1
    • If <48 hours with high stroke risk: Start IV heparin, LMWH, or direct oral anticoagulant before cardioversion 1
    • If <48 hours with low stroke risk: Consider IV heparin, LMWH, direct oral anticoagulant, or no anticoagulation 1
  2. Alternative approach for patients with atrial flutter ≥48 hours without 3 weeks of prior anticoagulation:

    • Perform transesophageal echocardiography (TEE) to exclude left atrial thrombus 1
    • If no thrombus is identified, proceed with cardioversion while ensuring anticoagulation is started before TEE and continued for at least 4 weeks after 1
    • Note: A normal TEE does not completely eliminate thromboembolic risk 2
  3. Establish IV access and attach the following:

    • Continuous cardiac monitoring
    • Blood pressure monitoring
    • Pulse oximetry
  4. Prepare emergency equipment:

    • Airway management supplies
    • Resuscitation cart with emergency medications

Procedural Steps

  1. Patient positioning and preparation:

    • Position patient supine
    • Administer sedation (typically midazolam or propofol) with monitoring by qualified personnel 3
    • Apply supplemental oxygen
  2. Electrode placement (two options):

    • Anterolateral position: One electrode on right upper chest and one over cardiac apex
    • Anteroposterior position: One electrode on anterior chest and one on back (may be more effective for atrial flutter)
  3. Energy selection:

    • Atrial flutter typically requires lower energy than atrial fibrillation 1
    • Start with 50-100 joules for biphasic defibrillators
    • If unsuccessful, increase energy in stepwise fashion
  4. Synchronization:

    • Ensure the defibrillator is in synchronized mode to avoid shock delivery during vulnerable period of cardiac cycle 1
    • Verify synchronization markers appear on R waves
  5. Cardioversion delivery:

    • Ensure all personnel are clear of patient and bed
    • Press and hold discharge buttons until shock is delivered
    • Immediately assess rhythm and vital signs
  6. Post-shock management:

    • If first shock fails, consider:
      • Repositioning electrodes
      • Applying pressure over electrodes
      • Increasing energy level
      • Administering antiarrhythmic medication before repeat attempt 1

Post-Cardioversion Care

  1. Immediate monitoring:

    • Continuous cardiac monitoring until patient fully recovered from sedation
    • Monitor vital signs every 15 minutes until stable
    • Assess for complications (bradycardia, hypotension, arrhythmias)
  2. Anticoagulation:

    • Continue anticoagulation for at least 4 weeks after successful cardioversion regardless of CHA₂DS₂-VASc score 1
    • Long-term anticoagulation should be based on thromboembolic risk profile 1
  3. Antiarrhythmic therapy:

    • Consider antiarrhythmic medications to maintain sinus rhythm if high risk of recurrence 1
    • Options include flecainide, propafenone, dofetilide, sotalol, or amiodaride based on patient's cardiac status 1

Special Considerations

  1. Hemodynamically unstable patients:

    • Proceed immediately to synchronized cardioversion 1
    • Anticoagulate as soon as possible and continue for at least 4 weeks 1
  2. Patients with pacing wires or implanted devices:

    • Consider rapid atrial pacing as an alternative to electrical cardioversion 1
    • Pace at a rate 5-10% above the atrial flutter rate for ≥15 seconds 1
    • Incrementally increase pacing rate until sinus rhythm or atrial fibrillation occurs 1
  3. Pre-excitation syndromes:

    • Avoid AV nodal blocking agents (digoxin, calcium channel blockers, beta-blockers) 1, 4
    • Proceed directly to cardioversion if hemodynamically unstable 1

Potential Complications

  • Thromboembolism (0.6-3% risk without adequate anticoagulation) 2, 5
  • Bradyarrhythmias or tachyarrhythmias
  • Skin burns at electrode sites
  • Sedation-related complications (respiratory depression, hypotension)

Follow-up

  • Schedule follow-up within 10 days of discharge 4
  • Monitor for recurrence of atrial flutter
  • Assess effectiveness of rate or rhythm control strategy
  • Consider repeated cardioversion if patient maintains sinus rhythm for clinically meaningful periods between procedures 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A prospective study of electrical cardioversion for sustained tachycardias by emergency unit personnel.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1995

Guideline

Atrial Fibrillation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.